Acute renal allograft rejection following pegylated IFN-α treatment for chronic HCV in a repeat allograft recipient on hemodialysis: A case report

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1746-1751

  Carbognin, S J ^a   Solomon, N M ^b   Yeo, F E ^a   Swanson, S J ^a   Bohen, E M ^a   Koff, J M ^a   Sabnis, S G ^a   Abbott, K C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Graft failure; Hepatitis C; Peg interferon

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; ERYTHROPOIETIN; FOLIC ACID; GENTAMICIN; LISINOPRIL; METHYLPREDNISOLONE; METOPROLOL; MYCOPHENOLIC ACID; PEGINTERFERON; PEGINTERFERON ALPHA2B; PREDNISONE; SIMVASTATIN; VANCOMYCIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CASE REPORT; CELLULITIS; CHRONIC HEPATITIS; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MALE; NEPHRECTOMY; PRIORITY JOURNAL; REOPERATION;

GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RENAL DIALYSIS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745362427     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01374.x     Document Type: Article

References (22)

1. Stehman-Breen CO Emerson S Gretch D Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998 32 : 629 634.
2. Mathurin P Mouquet C Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999 29 : 257 263.
3. Rostaing L Izopet J Baron E et al. Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients. Nephrol Dial Transplant 1995 10 ( Suppl 6 93 96.
4. Ozgur O Boyacioglu S Telatar H Haberal M. Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C. Nephrol Dial Transplant 1995 10 : 2104 2106.
5. Gane E Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002 74 : 427 437.
6. Meyers C Seeff L Stehman-Breen C Hoofnagle J. Hepatitis C and renal disease: An update. Am J Kidney Dis 2003 42 : 631 657.
7. Kamar N Toupance O Buchler M et al. Evidence that clearance of hepatitis C virus RNA after (-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003 14 : 2092 2098.
8. Gonzalez-Roncero F Gentil M Valdivia M et al. Outcome of kidney transplant in chronic hepatitis C virus patients: Effect of pretransplantation interferon-alpha2b monotherapy. Transplant Proc 2003 35 : 1745 1747.
9. Cruzado J Casanovas-Taltavull T Torras J Baliellas C Gil-Vernet S Grinyo J. Pretransplant Interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant 2003 3 : 357 360.
10. Campistol JM Esforzado N Martinez J et al. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment. Nephrol Dial Transplant 1999 14 : 2704 2709.
11. Russo MW Goldsweig CD Jacobson IM Brown RS Jr. Interferon monotherapy for dialysis patients with chronic hepatitis C: An analysis of the literature on efficacy and safety. Am J Gastroenterol 2003 98 : 1610 1615.
12. Fabrizi F Dulai G Dixit V Bunnapradist S Martin P. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003 18 : 1071 1081.
13. Baid S Tolkoff-Rubin N Saidman S et al. Acute humoral rejection in Hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant 2003 3 : 74 78.
14. Hanafusa T Ichikawa Y Yazawa K et al. Hepatitis C virus infection in kidney transplantation and a pilot study of the effects of interferon-alpha therapy. Transplant Proc. 1998 30 : 122 124.
15. Rostaing L Izopet J Baron E Duffaut M Puel J Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995 59 : 1426 1431.
16. Rivera M Gentil MA Sayago M et al. Treatment of hepatitis C virus with interferon in hemodialysis patients awaiting kidney transplant. Transplant Proc 2005 37 : 1424 1425.
17. Smak Gregoor PJ Zietse R van Saase JL et al. Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant 2001 15 : 397 401.
18. Kaplan B Meier-Kriesche HU. Death after graft loss: An important late study endpoint in kidney transplantation. Am J Transplant 2002 2 : 970 974.
19. Hanrotel C Toupance O Lavaud S et al. Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron 2001 88 : 120 126.
20. Thomas RM Brems JJ Guzman-Hartman G Yong S Cavaliere P Van Thiel DH. Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantation. Liver Transpl 2003 9 : 905 915.
21. Gentil MA Lopez M Gonzalez-Roncero F et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: Influence of new immunosuppression protocols. Transplant Proc 2003 35 : 1748 1750.
22. Fissell RB Bragg-Gresham JL Woods JD et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2004 65 : 2335 2342.